A long time ago
Unfortunately,
many women diagnosed with ovarian cancer find themselves in stage 3c, or even
stage 4. While not an automatic death
sentence, such a diagnosis is very bad news.
Thus it is encouraging that a small outfit based in San Francisco, Sutro
Biopharma, has successfully completed a Phase 1 trial that holds promise of
extended life, and possibly even complete re mission. Results are summarized in the link below.
To read it without excessive head scratching it might help to know that RECIST
stands for Response Evaluation Criteria in Solid Tumors, PR means partial
response, and CR stands for complete response
https://www.ajmc.com/view/phase-1-study-of-novel-drug-for-ovarian-cancer-shows-positive-results
No comments:
Post a Comment